Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Category: Pfizer
The neurodegenerative disease currently affects more than 200,000 people worldwide
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
The neurodegenerative disease currently affects more than 200,000 people worldwide